Delivery Order SPE2DB20D1109-SPE2DB25FP69H
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $30,339.39 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count units) under a firm fixed price arrangement. The award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's larger contract vehicle. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,085.09 by the Defense Logistics Agency on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract, issued under a firm fixed-price arrangement with no set-aside designation, covers the supply of Rexulti 2 mg tablets in a 30-count package. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $41,480.93 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Rexulti 1 mg tablets (30-count units). This firm fixed-price, competitively awarded contract with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,033.39 by the Defense Logistics Agency for the supply of Rexulti 2 mg tablets (30-count units). This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Rexulti 1 mg tablets (30-count units) with a ceiling value of $18,866.61. This non-set-aside contract award reflects a firm fixed price delivery order with an ultimate completion date of August 8, 2025. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a Delivery Order valued at $2,783.93 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction under AmerisourceBergen Drug Corp's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product Rexulti 2 mg tablets. The order, valued at $18,800.55, has an ultimate completion date of August 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a range...
- The Defense Logistics Agency awarded a delivery order valued at $8,429.48 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count) under a firm fixed price contract type. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, and reflects a non-competitive set-aside approach. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania, serving the federal medical supply chain...
- The Defense Logistics Agency awarded a $3,903.48 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Rexulti 2 mg on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order is issued without set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. The award represents a child order...
- The Defense Logistics Agency awarded a delivery order valued at $35,464.57 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Rexulti 0.5 mg tablets in quantities of 30. This firm fixed price delivery order, with an ultimate completion date of July 25, 2025, represents a pharmaceutical supply transaction supporting federal medical procurement needs. The award was competitively awarded with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP69HDelivery Order
The Defense Logistics Agency awarded a $10,602.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units), with an ultimate completion date of September 5, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and serves as a critical pharmaceutical distributor for federal medical procurement. This delivery order is part of AmerisourceBergen's extensive portfolio of federal contracts with the Defense Logistics Agency, which includes a significant Indefinite Delivery Contract valued at $999,999,999.00 through December 2026. The company supplies pharmaceutical products and medical commodities to support military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to fulfill competitive federal procurement requirements across a diverse range of medications and medical supplies, from brand-name treatments to generic drugs and specialty pharmaceuticals, positions the company as a key vendor within the federal medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 9/4/25 |